Results 81 to 90 of about 19,061 (206)

RAD‐SHIP—A New Model Called Rational Antibiotic Use‐Stewardship to Control Antimicrobial Use Intensity and Effectiveness in Hospitals

Journal of Clinical Pharmacy and Therapeutics, Volume 2026, Issue 1, 2026.
Background The increasing prevalence of antimicrobial resistance (AMR) poses a significant threat to global public health, primarily due to the irrational or excessive use of antimicrobial agents, which reduces or completely eliminates the sensitivity of microorganisms to drugs, complicating treatment.
Hua Gao, Ling Li, Hao Zhang, Wei Ma, Yafen Wang, Ali Imran   +5 more
wiley   +1 more source

PSY167 - COMPARISON OF PHARMACOECONOMIC (PE) EVALUATIONS FOR DRUGS FOR RARE DISEASES (DRDS) EVALUATED BY CADTH AND NICE. [PDF]

, 2018
Sheena Gosain, Ash Bullement, J. Kirby, Lewis Ralph, Cameron Lilley, Dale N. Lawrence   +5 more
openalex   +1 more source

Cost-effectiveness of Kang Ai injection plus chemotherapy vs. Shenqi Fuzheng injection plus chemotherapy in the first-line treatment of advanced non-small cell lung cancer

Frontiers in Medicine
ObjectiveThis study aimed to evaluate the cost-effectiveness of two Chinese patent medicines, including Kang Ai injection and Shenqi Fuzheng injection with each combined with platinum-based chemotherapy as the first-line treatment for patients with ...
Junjie Zhu, Junjie Zhu, Lei Tian, Lei Tian   +3 more
doaj   +1 more source

Cost Analysis of Haemodialysis Patients in Government Tertiary Care Centre – A Pharmacoeconomic Study [PDF]

, 2021
Manjula MJ, Deepak Pental, Rachana Suresh, N Raghu   +3 more
openalex   +1 more source

Identifying optimal ALK inhibitors in first- and second-line treatment of patients with advanced ALK-positive non-small-cell lung cancer: a systematic review and network meta-analysis

BMC Cancer
Objectives To compare the efficacy, safety and effects on quality of life of different ALK-inhibitors for global and Asian patients with advanced ALK-positive non-small-cell lung cancer (NSCLC).
Mingye Zhao, Taihang Shao, Hanqiao Shao, Caicun Zhou, Wenxi Tang   +4 more
doaj   +1 more source

Pharmacoeconomic assessment of hepatoprotectors used for prevention of developing post-resection acute liver failure after extensive hemihepatectomy due to colorectal cancer metastases [PDF]

, 2016
A.A. Pochuprina, A.Yu. Kulikov
openalex   +1 more source

Anaesthesia pharmacoeconomics [PDF]

Canadian Journal of Anaesthesia, 1993
openaire   +2 more sources

Pharmacoeconomic Analysis of Biologics and Methotrexate for Rheumatoid Arthritis from the Standpoint of the Number Needed to Treat Concept under the Japanese Health Insurance System [PDF]

, 2021
Kengo Harigane, Yuichi Mochida, Takayuki Shimazaki, Naomi Kobayashi, Yutaka Inaba   +4 more
openalex   +1 more source

Pharmacoeconomics: basic concepts and terminology [PDF]

, 1997
T Walley, Alan Haycox
openalex   +1 more source

Pharmacoeconomic advantages of using intrauterine levonorgestrel containing Mirena system in conjunction with the transdermal estrogen containing drugs for the treatment of menopausal syndrome and contraception during the menopausal transition

, 2016
N. G. Baeva, Yu.A. Filyaeva
openalex   +1 more source